Bioreactors Top Companies-Recent Developments, Business Strategy, Deal Strategy, Patent Strategy, Benchmarking and Management Outlook

Date : November 2024

Bioreactors Market Size Analysis and Top Companies

The global bioreactors market size is estimated at to hit around USD 34.24 billion by 2033 from USD 11.79 billion in 2024 with a CAGR of 12.58% from 2024 tpo 2033. The top companies operating in the bioreactors market are GE Healthcare, Merck KGaA, Eppendorf AG, Sartorius AG, Thermo Fisher Scientific Inc., BBI-Biotech GmbH, Bioengineering AG, Danaher Corporation, Getinge, Infos HT, Solaris Biotech Solutions and Others.

Market Scope

Report Coverage Details
Market Size in 2024 USD 11.79 Billion
Market Size by 2034 USD 38.55Billion
Growth Rate from 2024 to 2034 CAGR of 12.58%
Base Year 2023
Forecast Period 2024 to 2034
Segments Covered By Product Type, By Cell, By Molecule, By Usage and By End-Use
Regions Covered North America, Europe, Asia-Pacific, Latin America and Middle East & Africa

Bioreactors Market Companies

  • GE Healthcare
  • Merck KGaA
  • Eppendorf AG
  • Sartorius AG
  • Thermo Fisher Scientific Inc.
  • BBI-Biotech GmbH
  • Bioengineering AG
  • Danaher Corporation
  • Getinge
  • Infos HT
  • Solaris Biotech Solutions

Recent Developments

  • The biotechnology company Freeline entered in a partnership with another organization, Pall corporation in the year 2019. This partnership was formed for the implementation of the bioreactor system of iCELLis with Freeline organization's AAV platform of manufacturing.
  • Sartorius Stedim biotech into a partnership with Repligen corporation in 2019 for the introduction of the next Gen bioreactors that are perfusion enabled.

We have prepared a service to support you. please feel free to contact us at sales@precedenceresearch.com | +1 804 441 9344